Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
capicua transcriptional repressor pseudogene 19 (CICP19) is one of several human genomic DNA sequences closely related to the functional capicua transcriptional repressor gene (CIC), but does not encode a functional protein. Pseudogenes such as CICP19 are typically noncoding and can arise either by duplication or retrotransposition of functional genes. The functional CIC gene is a high-mobility group (HMG) box transcription factor involved in DNA binding and regulation of gene expression, and is implicated in various diseases, including certain cancers. However, there is no evidence that CICP19 fulfills any protein-coding or specific regulatory role, nor is it considered a drug target[2][3][4]. Summary: capicua transcriptional repressor pseudogene 19 (CICP19) is a *pseudogene* with no known functional, disease, or therapeutic relevance. It is not a receptor, enzyme, transporter, or transcription factor, and is not a recognized target in drug discovery or biomarker research[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on capicua transcriptional repressor pseudogene 19 (CICP19).